Akebia Therapeutics (AKBA) Receivables - Net (2013 - 2026)
Akebia Therapeutics (AKBA) posted Receivables - Net of $53.51 million for Q2 2026, down 59.1% from $130.8 million a year earlier and down 14.4% from the prior quarter.
Powered by 
Analysis
Akebia Therapeutics (AKBA) Receivables - Net (2013 - 2026) Analysis & Trends
At the end of FY2025, Akebia Therapeutics' Receivables - Net came in at $47.03 million, up 36.8% from FY2024.
- Annual Receivables - Net shows a five-year compound annual growth rate of 11.9% (FY2020 to FY2025).
- In prior years, Akebia Therapeutics' Receivables - Net was $34.37 million in FY2024 (-12.5%), $39.29 million in FY2023 (-2.5%), $40.28 million in FY2022 (-21.9%) and $51.58 million in FY2021 (+92.1%).
- Quarterly Receivables - Net has run from a low of $18.73 million in Q1 2023 to a high of $130.8 million in Q2 2025 over five years.
- On a year-over-year basis, Receivables - Net increased in six of the last eight quarters, with growth averaging 73.2%.
- The strongest year-over-year quarter for Receivables - Net in the past five years was Q2 2025, with growth of 339.4%; the weakest was Q2 2023, with a decline of 76.1%.
- According to Business Quant data, Receivables - Net for the three prior quarters was $62.54 million (Q1 2026), $47.03 million (Q4 2025) and $66.22 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Akebia Therapeutics | 241.85 Mn | -427.63 Mn | 38.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 53.51 Mn |
| Mar 31, 2026 | 62.54 Mn |
| Dec 31, 2025 | 47.03 Mn |
| Sep 30, 2025 | 66.22 Mn |
| Jun 30, 2025 | 130.80 Mn |
| Mar 31, 2025 | 61.54 Mn |
| Dec 31, 2024 | 34.37 Mn |
| Sep 30, 2024 | 32.17 Mn |
| Jun 30, 2024 | 29.77 Mn |
| Mar 31, 2024 | 26.62 Mn |
| Dec 31, 2023 | 39.29 Mn |
| Sep 30, 2023 | 22.59 Mn |
| Jun 30, 2023 | 19.57 Mn |
| Mar 31, 2023 | 18.73 Mn |
| Dec 31, 2022 | 40.28 Mn |
| Sep 30, 2022 | 23.27 Mn |
| Jun 30, 2022 | 82.00 Mn |
| Mar 31, 2022 | 65.36 Mn |
| Dec 31, 2021 | 51.58 Mn |
| Sep 30, 2021 | 49.69 Mn |
API Access
Akebia Therapeutics Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=AKBA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "AKBA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=AKBA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();